StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > ⚡⚡⚡ SZLS should focus on Aristotle, forget covid tests

<< Previous

Bullboard Posts

Next >>

Comment by frewil11on May 12, 2021 3:30pm

96 Views

Post# 33184597

RE:RE:RE:RE:RE:RE:RE:RE:⚡⚡⚡ SZLS should focus on Aristotle, forget covid tests

The big question to ask at CC on Monday morning , IS STAGE ZERO PERFORMING ANY ARISTOTLE TESTING , YES OR NO AND HOW MANY , it is alright for JHT to let investors know.

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale